Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharmacyclics reports phase I results for Lu-Tex

May 22, 1997

No Comments

Interim results with Pharmacyclics' Gd-Tex reported at ASCO

May 22, 1997

No Comments

Encouraging results reported for ImClone's lead cancer therapeutic agent

May 22, 1997

No Comments

Onyx reports clinical results of anticancer viral therapeutic at ASCO meeting

May 22, 1997

No Comments

Diaziridinylpolyamines as anticancer agents claimed by U. of Maryland

May 22, 1997

No Comments

Aronex reports clinical progress of Annamycin

May 21, 1997

No Comments

Preliminary phase I/II results for Vertex's VX-710

May 21, 1997

No Comments

Gensia receives ANDA approval for etoposide injection

May 21, 1997

No Comments

Update on Onconase clinical trials

May 20, 1997

No Comments

Purdue Pharma licenses anticancer chimeric

May 20, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cancer
RSS

Pharmacyclics reports phase I results for Lu-Tex

Interim results with Pharmacyclics' Gd-Tex reported at ASCO

Encouraging results reported for ImClone's lead cancer therapeutic agent

Onyx reports clinical results of anticancer viral therapeutic at ASCO meeting

Diaziridinylpolyamines as anticancer agents claimed by U. of Maryland

Aronex reports clinical progress of Annamycin

Preliminary phase I/II results for Vertex's VX-710

Gensia receives ANDA approval for etoposide injection

Update on Onconase clinical trials

Purdue Pharma licenses anticancer chimeric

Today's news in brief

Today's news in brief

Boryung invests $10M in Intuitive Machines for outer space R&D

Phase II Huntington’s tie-up with Novartis could edge $3B for PTC

Tolerogenic assets at heart of Cour-Genentech $940M autoimmune deal

Cancer RSS

Cancer
RSS